Bank Of America Corp Aeterna Zentaris Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.17 - $0.37 $850 - $1,850	5,000 Added 50000.0%	5,010 $1,000
Q4 2021 Feb 08, 2022	SELL	$0.36 - $0.77 $1,368 - $2,926	-3,800 Reduced 99.74%	10 $0
Q3 2021 Nov 15, 2021	SELL	$0.59 - $0.88 $2,360 - $3,520	-4,000 Reduced 51.22%	3,810 $3,000
Q2 2021 Sep 13, 2021	BUY	$0.83 - $1.14 $6,482 - $8,903	7,810 New	7,810 $7,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.